Risk of Viral Transmission Via Bone Marrow Progenitor Cells Versus Umbilical Cord Blood Hematopoietic Stem Cells in Bone Marrow Transplantation
Hematopoietic stem cell transplantation (HSCT) is the treatment of choice for children and certain adults with malignant and nonmalignant hematologic disease. Since viral infections are the major problem, this study examined those that might potentially be transmitted to HSCT recipients via bone mar...
Gespeichert in:
| Veröffentlicht in: | Transplantation proceedings 2005-09, Vol.37 (7), p.3211-3212 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3212 |
|---|---|
| container_issue | 7 |
| container_start_page | 3211 |
| container_title | Transplantation proceedings |
| container_volume | 37 |
| creator | Behzad-Behbahani, A. Pouransari, R. Tabei, S.Z. Rahiminejad, M.S. Robati, M. Yaghobi, R. Nourani, H. Ramzi, M.M. Farhadi-Andarabi, A. Mojiri, A. Rahsaz, M. Banihashemi, M. Zare, N. |
| description | Hematopoietic stem cell transplantation (HSCT) is the treatment of choice for children and certain adults with malignant and nonmalignant hematologic disease. Since viral infections are the major problem, this study examined those that might potentially be transmitted to HSCT recipients via bone marrow (BM) versus umbilical cord blood (UCB). BM progenitor cells, peripheral blood leukocytes, and plasma samples were collected from 30 allogenic BM donors. Umbilical cord blood hematopoietic stem cells and plasma samples were also collected from 34 UCB donors. Viral DNA extracted and purified from collected specimens was processed using nested polymerase chain reactions (PCR) to detect human parvovirus B19 (HPV B19), human herpesvirus-6 (HHV-6), varicella-zoster virus (VZV), human cytomegalovirus (HCMV), and Epstein-Barr virus (EBV). The prevalences of HCMV DNA in collected BM progenitor cells versus UCB hematopoietic stem cells were 73% versus 23%, respectively. Conversely, HHV-6 DNA was not detected in any collected specimen by simple PCR. Distribution of the other investigated virus DNAs except EBV DNA was similar in specimens collected from both groups. EBV DNA was not determined in UCB hematopoietic stem cells. The results indicate that the risk of viral transmission to BM transplant recipients via UCB hematopoietic stem cells is less than that with BM progenitor cells. |
| doi_str_mv | 10.1016/j.transproceed.2005.07.007 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68671513</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041134505007505</els_id><sourcerecordid>68671513</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-caf5c686a7fb918b01e2cbd7b94e32092dff7a528d7d98fff8470abb15a1d1ed3</originalsourceid><addsrcrecordid>eNqNUcuOFCEUJUbjtK2_YIiJ7qrkQlVR7c5pH2MyRqMzsyUUXAxtVdECrfEr_GVpu-Jj54rAPY_LOYQ8AlYDg-7prs5Rz2kfg0G0NWesrZmsGZO3yAp6KSrecXGbrBhroALRtGfkXko7Vu68EXfJGXQchGjZivz44NNnGhy98VGP9OooPPmUfJjLk6bnYUb6VscYvtH3MXzC2ecQ6RbHMdEbjOmQ6PU0-NGbQt-GaOn5GIKlFzjpHPbBY_aGfsw4LSQ__yP6y3E_6jnrXEzvkztOjwkfLOeaXL96ebW9qC7fvX6zfX5ZmUY2uTLatabrOy3dsIF-YIDcDFYOmwYFZxtunZO65b2VdtM75_pGMj0M0GqwgFasyZOTbknxywFTVuXXpiyoZwyHpIq2hLaEtCbPTkATQ0oRndpHP-n4XQFTxzrUTv1dhzrWoZhUpY5Cfri4HIapzH5Tl_wL4PEC0KkE6IqQ8ekPTgqQAFBwL044LJl89RhVMh5ng9ZHNFnZ4P9nn5-jm7L-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68671513</pqid></control><display><type>article</type><title>Risk of Viral Transmission Via Bone Marrow Progenitor Cells Versus Umbilical Cord Blood Hematopoietic Stem Cells in Bone Marrow Transplantation</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Behzad-Behbahani, A. ; Pouransari, R. ; Tabei, S.Z. ; Rahiminejad, M.S. ; Robati, M. ; Yaghobi, R. ; Nourani, H. ; Ramzi, M.M. ; Farhadi-Andarabi, A. ; Mojiri, A. ; Rahsaz, M. ; Banihashemi, M. ; Zare, N.</creator><creatorcontrib>Behzad-Behbahani, A. ; Pouransari, R. ; Tabei, S.Z. ; Rahiminejad, M.S. ; Robati, M. ; Yaghobi, R. ; Nourani, H. ; Ramzi, M.M. ; Farhadi-Andarabi, A. ; Mojiri, A. ; Rahsaz, M. ; Banihashemi, M. ; Zare, N.</creatorcontrib><description>Hematopoietic stem cell transplantation (HSCT) is the treatment of choice for children and certain adults with malignant and nonmalignant hematologic disease. Since viral infections are the major problem, this study examined those that might potentially be transmitted to HSCT recipients via bone marrow (BM) versus umbilical cord blood (UCB). BM progenitor cells, peripheral blood leukocytes, and plasma samples were collected from 30 allogenic BM donors. Umbilical cord blood hematopoietic stem cells and plasma samples were also collected from 34 UCB donors. Viral DNA extracted and purified from collected specimens was processed using nested polymerase chain reactions (PCR) to detect human parvovirus B19 (HPV B19), human herpesvirus-6 (HHV-6), varicella-zoster virus (VZV), human cytomegalovirus (HCMV), and Epstein-Barr virus (EBV). The prevalences of HCMV DNA in collected BM progenitor cells versus UCB hematopoietic stem cells were 73% versus 23%, respectively. Conversely, HHV-6 DNA was not detected in any collected specimen by simple PCR. Distribution of the other investigated virus DNAs except EBV DNA was similar in specimens collected from both groups. EBV DNA was not determined in UCB hematopoietic stem cells. The results indicate that the risk of viral transmission to BM transplant recipients via UCB hematopoietic stem cells is less than that with BM progenitor cells.</description><identifier>ISSN: 0041-1345</identifier><identifier>EISSN: 1873-2623</identifier><identifier>DOI: 10.1016/j.transproceed.2005.07.007</identifier><identifier>PMID: 16213350</identifier><identifier>CODEN: TRPPA8</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Blood Donors ; Bone Marrow Transplantation - adverse effects ; Bone marrow, stem cells transplantation. Graft versus host reaction ; DNA, Viral - genetics ; DNA, Viral - isolation & purification ; Fetal Blood ; Fundamental and applied biological sciences. Psychology ; Fundamental immunology ; Humans ; Medical sciences ; Plasmids ; Polymerase Chain Reaction ; Risk Factors ; Stem Cell Transplantation - adverse effects ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Tissue, organ and graft immunology ; Transfusions. Complications. Transfusion reactions. Cell and gene therapy ; Umbilical Veins ; Virus Diseases - classification ; Virus Diseases - transmission</subject><ispartof>Transplantation proceedings, 2005-09, Vol.37 (7), p.3211-3212</ispartof><rights>2005 Elsevier Inc.</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-caf5c686a7fb918b01e2cbd7b94e32092dff7a528d7d98fff8470abb15a1d1ed3</citedby><cites>FETCH-LOGICAL-c474t-caf5c686a7fb918b01e2cbd7b94e32092dff7a528d7d98fff8470abb15a1d1ed3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0041134505007505$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,776,780,785,786,3537,23909,23910,25118,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17317111$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16213350$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Behzad-Behbahani, A.</creatorcontrib><creatorcontrib>Pouransari, R.</creatorcontrib><creatorcontrib>Tabei, S.Z.</creatorcontrib><creatorcontrib>Rahiminejad, M.S.</creatorcontrib><creatorcontrib>Robati, M.</creatorcontrib><creatorcontrib>Yaghobi, R.</creatorcontrib><creatorcontrib>Nourani, H.</creatorcontrib><creatorcontrib>Ramzi, M.M.</creatorcontrib><creatorcontrib>Farhadi-Andarabi, A.</creatorcontrib><creatorcontrib>Mojiri, A.</creatorcontrib><creatorcontrib>Rahsaz, M.</creatorcontrib><creatorcontrib>Banihashemi, M.</creatorcontrib><creatorcontrib>Zare, N.</creatorcontrib><title>Risk of Viral Transmission Via Bone Marrow Progenitor Cells Versus Umbilical Cord Blood Hematopoietic Stem Cells in Bone Marrow Transplantation</title><title>Transplantation proceedings</title><addtitle>Transplant Proc</addtitle><description>Hematopoietic stem cell transplantation (HSCT) is the treatment of choice for children and certain adults with malignant and nonmalignant hematologic disease. Since viral infections are the major problem, this study examined those that might potentially be transmitted to HSCT recipients via bone marrow (BM) versus umbilical cord blood (UCB). BM progenitor cells, peripheral blood leukocytes, and plasma samples were collected from 30 allogenic BM donors. Umbilical cord blood hematopoietic stem cells and plasma samples were also collected from 34 UCB donors. Viral DNA extracted and purified from collected specimens was processed using nested polymerase chain reactions (PCR) to detect human parvovirus B19 (HPV B19), human herpesvirus-6 (HHV-6), varicella-zoster virus (VZV), human cytomegalovirus (HCMV), and Epstein-Barr virus (EBV). The prevalences of HCMV DNA in collected BM progenitor cells versus UCB hematopoietic stem cells were 73% versus 23%, respectively. Conversely, HHV-6 DNA was not detected in any collected specimen by simple PCR. Distribution of the other investigated virus DNAs except EBV DNA was similar in specimens collected from both groups. EBV DNA was not determined in UCB hematopoietic stem cells. The results indicate that the risk of viral transmission to BM transplant recipients via UCB hematopoietic stem cells is less than that with BM progenitor cells.</description><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Blood Donors</subject><subject>Bone Marrow Transplantation - adverse effects</subject><subject>Bone marrow, stem cells transplantation. Graft versus host reaction</subject><subject>DNA, Viral - genetics</subject><subject>DNA, Viral - isolation & purification</subject><subject>Fetal Blood</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fundamental immunology</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Plasmids</subject><subject>Polymerase Chain Reaction</subject><subject>Risk Factors</subject><subject>Stem Cell Transplantation - adverse effects</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Tissue, organ and graft immunology</subject><subject>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><subject>Umbilical Veins</subject><subject>Virus Diseases - classification</subject><subject>Virus Diseases - transmission</subject><issn>0041-1345</issn><issn>1873-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUcuOFCEUJUbjtK2_YIiJ7qrkQlVR7c5pH2MyRqMzsyUUXAxtVdECrfEr_GVpu-Jj54rAPY_LOYQ8AlYDg-7prs5Rz2kfg0G0NWesrZmsGZO3yAp6KSrecXGbrBhroALRtGfkXko7Vu68EXfJGXQchGjZivz44NNnGhy98VGP9OooPPmUfJjLk6bnYUb6VscYvtH3MXzC2ecQ6RbHMdEbjOmQ6PU0-NGbQt-GaOn5GIKlFzjpHPbBY_aGfsw4LSQ__yP6y3E_6jnrXEzvkztOjwkfLOeaXL96ebW9qC7fvX6zfX5ZmUY2uTLatabrOy3dsIF-YIDcDFYOmwYFZxtunZO65b2VdtM75_pGMj0M0GqwgFasyZOTbknxywFTVuXXpiyoZwyHpIq2hLaEtCbPTkATQ0oRndpHP-n4XQFTxzrUTv1dhzrWoZhUpY5Cfri4HIapzH5Tl_wL4PEC0KkE6IqQ8ekPTgqQAFBwL044LJl89RhVMh5ng9ZHNFnZ4P9nn5-jm7L-</recordid><startdate>20050901</startdate><enddate>20050901</enddate><creator>Behzad-Behbahani, A.</creator><creator>Pouransari, R.</creator><creator>Tabei, S.Z.</creator><creator>Rahiminejad, M.S.</creator><creator>Robati, M.</creator><creator>Yaghobi, R.</creator><creator>Nourani, H.</creator><creator>Ramzi, M.M.</creator><creator>Farhadi-Andarabi, A.</creator><creator>Mojiri, A.</creator><creator>Rahsaz, M.</creator><creator>Banihashemi, M.</creator><creator>Zare, N.</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050901</creationdate><title>Risk of Viral Transmission Via Bone Marrow Progenitor Cells Versus Umbilical Cord Blood Hematopoietic Stem Cells in Bone Marrow Transplantation</title><author>Behzad-Behbahani, A. ; Pouransari, R. ; Tabei, S.Z. ; Rahiminejad, M.S. ; Robati, M. ; Yaghobi, R. ; Nourani, H. ; Ramzi, M.M. ; Farhadi-Andarabi, A. ; Mojiri, A. ; Rahsaz, M. ; Banihashemi, M. ; Zare, N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-caf5c686a7fb918b01e2cbd7b94e32092dff7a528d7d98fff8470abb15a1d1ed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Blood Donors</topic><topic>Bone Marrow Transplantation - adverse effects</topic><topic>Bone marrow, stem cells transplantation. Graft versus host reaction</topic><topic>DNA, Viral - genetics</topic><topic>DNA, Viral - isolation & purification</topic><topic>Fetal Blood</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fundamental immunology</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Plasmids</topic><topic>Polymerase Chain Reaction</topic><topic>Risk Factors</topic><topic>Stem Cell Transplantation - adverse effects</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Tissue, organ and graft immunology</topic><topic>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</topic><topic>Umbilical Veins</topic><topic>Virus Diseases - classification</topic><topic>Virus Diseases - transmission</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Behzad-Behbahani, A.</creatorcontrib><creatorcontrib>Pouransari, R.</creatorcontrib><creatorcontrib>Tabei, S.Z.</creatorcontrib><creatorcontrib>Rahiminejad, M.S.</creatorcontrib><creatorcontrib>Robati, M.</creatorcontrib><creatorcontrib>Yaghobi, R.</creatorcontrib><creatorcontrib>Nourani, H.</creatorcontrib><creatorcontrib>Ramzi, M.M.</creatorcontrib><creatorcontrib>Farhadi-Andarabi, A.</creatorcontrib><creatorcontrib>Mojiri, A.</creatorcontrib><creatorcontrib>Rahsaz, M.</creatorcontrib><creatorcontrib>Banihashemi, M.</creatorcontrib><creatorcontrib>Zare, N.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Behzad-Behbahani, A.</au><au>Pouransari, R.</au><au>Tabei, S.Z.</au><au>Rahiminejad, M.S.</au><au>Robati, M.</au><au>Yaghobi, R.</au><au>Nourani, H.</au><au>Ramzi, M.M.</au><au>Farhadi-Andarabi, A.</au><au>Mojiri, A.</au><au>Rahsaz, M.</au><au>Banihashemi, M.</au><au>Zare, N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk of Viral Transmission Via Bone Marrow Progenitor Cells Versus Umbilical Cord Blood Hematopoietic Stem Cells in Bone Marrow Transplantation</atitle><jtitle>Transplantation proceedings</jtitle><addtitle>Transplant Proc</addtitle><date>2005-09-01</date><risdate>2005</risdate><volume>37</volume><issue>7</issue><spage>3211</spage><epage>3212</epage><pages>3211-3212</pages><issn>0041-1345</issn><eissn>1873-2623</eissn><coden>TRPPA8</coden><abstract>Hematopoietic stem cell transplantation (HSCT) is the treatment of choice for children and certain adults with malignant and nonmalignant hematologic disease. Since viral infections are the major problem, this study examined those that might potentially be transmitted to HSCT recipients via bone marrow (BM) versus umbilical cord blood (UCB). BM progenitor cells, peripheral blood leukocytes, and plasma samples were collected from 30 allogenic BM donors. Umbilical cord blood hematopoietic stem cells and plasma samples were also collected from 34 UCB donors. Viral DNA extracted and purified from collected specimens was processed using nested polymerase chain reactions (PCR) to detect human parvovirus B19 (HPV B19), human herpesvirus-6 (HHV-6), varicella-zoster virus (VZV), human cytomegalovirus (HCMV), and Epstein-Barr virus (EBV). The prevalences of HCMV DNA in collected BM progenitor cells versus UCB hematopoietic stem cells were 73% versus 23%, respectively. Conversely, HHV-6 DNA was not detected in any collected specimen by simple PCR. Distribution of the other investigated virus DNAs except EBV DNA was similar in specimens collected from both groups. EBV DNA was not determined in UCB hematopoietic stem cells. The results indicate that the risk of viral transmission to BM transplant recipients via UCB hematopoietic stem cells is less than that with BM progenitor cells.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>16213350</pmid><doi>10.1016/j.transproceed.2005.07.007</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0041-1345 |
| ispartof | Transplantation proceedings, 2005-09, Vol.37 (7), p.3211-3212 |
| issn | 0041-1345 1873-2623 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68671513 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Blood Donors Bone Marrow Transplantation - adverse effects Bone marrow, stem cells transplantation. Graft versus host reaction DNA, Viral - genetics DNA, Viral - isolation & purification Fetal Blood Fundamental and applied biological sciences. Psychology Fundamental immunology Humans Medical sciences Plasmids Polymerase Chain Reaction Risk Factors Stem Cell Transplantation - adverse effects Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Tissue, organ and graft immunology Transfusions. Complications. Transfusion reactions. Cell and gene therapy Umbilical Veins Virus Diseases - classification Virus Diseases - transmission |
| title | Risk of Viral Transmission Via Bone Marrow Progenitor Cells Versus Umbilical Cord Blood Hematopoietic Stem Cells in Bone Marrow Transplantation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T15%3A13%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20of%20Viral%20Transmission%20Via%20Bone%20Marrow%20Progenitor%20Cells%20Versus%20Umbilical%20Cord%20Blood%20Hematopoietic%20Stem%20Cells%20in%20Bone%20Marrow%20Transplantation&rft.jtitle=Transplantation%20proceedings&rft.au=Behzad-Behbahani,%20A.&rft.date=2005-09-01&rft.volume=37&rft.issue=7&rft.spage=3211&rft.epage=3212&rft.pages=3211-3212&rft.issn=0041-1345&rft.eissn=1873-2623&rft.coden=TRPPA8&rft_id=info:doi/10.1016/j.transproceed.2005.07.007&rft_dat=%3Cproquest_cross%3E68671513%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68671513&rft_id=info:pmid/16213350&rft_els_id=S0041134505007505&rfr_iscdi=true |